GlassScriptPhysician profile
Richard Mohammed
NPI 1356960298
$1,757.21
in general payments reported to CMS, 2019-2025
22 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.28 · 2021: $244 · 2022: $819 · 2023: $291 · 2024: $119 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $253.36 | 2021-2023 | Repatha |
| Abbvie INC. | $232.22 | 2022-2025 | |
| Novo Nordisk INC | $171.11 | 2022-2025 | Ozempic |
| Pfizer INC. | $161.50 | 2020-2023 | |
| Lilly USA, LLC | $160.18 | 2022-2023 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $119.41 | 2024 | Breztri |
| Janssen Pharmaceuticals, INC | $106.32 | 2022 | |
| Insmed, INC. | $104.55 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.14 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $75.47 | 2022-2023 | Eliquis |
| Kiniksa Pharmaceuticals, LTD. | $72.56 | 2022 | |
| Genzyme Corporation | $39.56 | 2022 | |
| Janssen Scientific Affairs, LLC | $21.50 | 2023 | Xarelto |
| Janssen Biotech, INC. | $20.67 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $19.54 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.72 | 2022 | |
| Exact Sciences Corporation | $17.61 | 2023 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $17.52 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.60 | 2023 | Lifevest |
| Teleflex LLC | $16.05 | 2025 | Titan Sgs Bailout Chuck |
| Alnylam Pharmaceuticals INC. | $14.52 | 2023 | Onpattro |
| Organon LLC | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.